SUBSCRIBE

Breaking News on Global Pharmaceutical Technology & Manufacturing

Ingredients: Top Headlines

Synthon sells Czech plant to Mercachem in API consolidation move

08-Sep-2014 - Synthon has consolidated its Czech API capabilities through the sale of a laboratory and pilot scale plant in Prague to CRO Mercachem.

Related news

News in brief

News in brief

Evonik invests in Japanese silica capacity

08-Sep-2014 - Chemicals firm Evonik has expanded its capacity in Japan to cope with high demands for specialty silica, used in various drugmaking operations.

ISPE offers preview to drug shortages prevention plan

08-Sep-2014 - The International Society for Pharmaceutical Engineering (ISPE) last week offered up a preview to its plan to help manufacturers avoid or mitigate drug shortages due to manufacturing or quality issues.

Xellia says it planned to invest in Raleigh plant before new tax deal

04-Sep-2014 - Xellia has agreed to invest $100m in equipment, retain staff and create 40 full time jobs at the plant it bought in Raleigh, North Carolina in return for business incentives. 

400 R&D jobs cut as Novo Nordisk says goodbye to inflammatory work

03-Sep-2014 - Novo Nordisk has scrapped all its inflammatory disease therapy development programmes, cutting 400 jobs. 

Stem cells made available for API development by European biobank

02-Sep-2014 - A German biobank has made stem cells available to API firms this week in a bid to support industry drug development efforts.

Merck KGaA biopharma division to make small molecule drugs in China

29-Aug-2014 - Biopharmaceutical firm Merck Serono will make small molecule drugs at the new plant it is building in China according to a company spokeswoman, who told us the firm will supply both local and international markets.

GSK: GM yeast breakthrough won't kill off poppy-based opium

28-Aug-2014 - Poppies will continue to be the main source of industrial opiates long-term according to GSK, despite a recent breakthrough in efforts to produce it in GM yeast.

Ingredients: Featured news

Spotlight

SCM's woes part of UK-wide aseptic slowdown, says ex-owner

SCM's woes part of UK-wide aseptic slowdown, says ex-owner

GMP failures at an aseptic plant owned by SCM Pharma are part of a wider industry trend...

Boehringer aims to cut German costs 15% as H1 sales fall

Boehringer Ingelheim aims to cut German costs 15% as revenues drop

German jobs are safe despite a programme that will cut the cost of operations by 15%, Boehringer...

WHO: Data from use of unapproved Ebola drugs should be shared

WHO: Data from use of unapproved Ebola drugs should be shared

Efficacy and safety data from use of unapproved Ebola virus treatments should be shared according to an...

THC may reduce tumor size? mouse study investigates

THC may reduce tumor size? mouse study investigates

A previously unknown signaling platform may be responsible for the success of the main psychoactive ingredient in...

India’s CDSCO outlines procedures for state manufacturer inspections

India’s CDSCO outlines procedures for state inspections of manufacturers

In order to ensure uniformity on the state and federal levels, India’s CDSCO (Central Drugs Standard Control...

Roche re-enters RNAi space with $250m Santaris acquisition

Roche re-enters gene silencing space with $250m LNA acquisition

Roche has renewed its interest in gene silencing drugs, paying $250m (€187m) for Santaris Pharma including its...

Key Industry Events

 

Access all events listing

Our events, Events from partners...